Tevogen rises on plans to buy majority stake in digital health firm Sciometrix

Tevogen

26/02/2026 14:35

** Shares of drug developer Tevogen Bio TVGN.O rise 13.7% to 33 cents premarket

** Co signs letter of intent to buy a majority stake in Sciometrix; if deal goes through Tevogen to get access to the Clinicus digital care platform and remote-monitoring tools

** Says Sciometrix tech could help Tevogen generate revenue, support value-based care push, and speed drug development

** Financial terms were not disclosed; deal depends on due diligence, further talks, and regulatory approvals - Tevogen

** TVGN shares down ~68% in 2025

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))